MOVE: Movano Inc. Stock

by  •  • Comments Off on MOVE: Movano Inc. Stock

SIC 3845 – Electromedical and Electrotherapeutic Apparatus

Valuation
Market Cap ($M) 6.21
Enterprise Value ($M) -1.69
Book Value ($M) 7.36
Book Value / Share 1.05
Price / Book 0.84
NCAV ($M) 6.42
NCAV / Share 0.91
Price / NCAV 0.97

Profitability (mra)
Return on Invested Capital (ROIC) -2.95
Return on Assets (ROA) -4.62
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.42
Current Ratio 3.02

Balance Sheet (mrq) ($M)
Current Assets 10.39
Assets 11.32
Liabilities 3.96
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.01
Operating Income -24.22
Net Income -23.73

Cash Flow Statement (mra) ($M)
Cash From Operations -22.53
Cash from Investing -0.01
Cash from Financing 24.32

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2024-04-10 13G Appel Peter A 9.99
2024-04-09 13G/A Tamkin Gregory S 7.66 99.46

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-09 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 ☐ TRANSITION REPORT PURSUA
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2024 ☐ TRANSITION REPO
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2024 ☐ TRANSITION REPORT PU
2024-05-17 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2024 ☐ TRANSITION REPORT P

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-29 8,007 17,564 45.59
2025-04-28 10,766 27,249 39.51
2025-04-25 275 3,033 9.07
2025-04-24 22,175 44,576 49.75

(click for more detail)

Similar Companies
MDXG – MiMedx Group, Inc. MGRM – Monogram Technologies Inc.
MODD – Modular Medical, Inc. NAOV – NanoVibronix, Inc.
NDRA – ENDRA Life Sciences Inc.


Financial data and stock pages provided by
Fintel.io